GRHL2 and prostate carcinoma: Several studies have shown that GRHL2 showed a different degree of expression in a wide variety of tumor tissues, including epithelial squamous cell cancer, breast carcinoma, gastrointestinal cancer, liver cell cancer, colon cancer, renal carcinoma, cervical cancer, neuroblastoma, and prostate cancer.